Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Comparative effectiveness of inhaled corticosteroids for paediatric asthma: protocol for a systematic review and Bayesian network meta-analysis.

Takeuchi M, Kano H, Takahashi K, Iwata T.

BMJ Open. 2015 Oct 22;5(10):e008501. doi: 10.1136/bmjopen-2015-008501.

2.

Academic-Industry Research Partnerships: an Emerging Opportunity or Just Smoke and Mirrors?

Hochman M, Bedard R.

J Gen Intern Med. 2016 Feb;31(2):149-50. doi: 10.1007/s11606-015-3527-8. No abstract available.

PMID:
26453456
3.

The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children.

Dunn AG, Mandl KD, Coiera E, Bourgeois FT.

PLoS One. 2013 Dec 23;8(12):e84951. doi: 10.1371/journal.pone.0084951. eCollection 2013.

4.

Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review.

Bafeta A, Trinquart L, Seror R, Ravaud P.

BMJ. 2013 Jul 1;347:f3675. doi: 10.1136/bmj.f3675. Review.

5.
6.

Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for comparative effectiveness research.

Lowry SJ, Loggers ET, Bowles EJ, Wagner EH.

J Oncol Pract. 2012 May;8(3 Suppl):28s-33s. doi: 10.1200/JOP.2012.000569.

7.

The missing link in preconceptional care: the role of comparative effectiveness research.

Salihu HM, Salinas A, Mogos M.

Matern Child Health J. 2013 Jul;17(5):776-82. doi: 10.1007/s10995-012-1056-1.

8.

Participants' experiences of being debriefed to placebo allocation in a clinical trial.

Bishop FL, Jacobson EE, Shaw J, Kaptchuk TJ.

Qual Health Res. 2012 Aug;22(8):1138-49. doi: 10.1177/1049732312448544. Epub 2012 Jun 6.

9.

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.

Trinquart L, Abbé A, Ravaud P.

PLoS One. 2012;7(4):e35219. doi: 10.1371/journal.pone.0035219. Epub 2012 Apr 20.

10.

Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.

Bourgeois FT, Murthy S, Mandl KD.

PLoS One. 2012;7(1):e28820. doi: 10.1371/journal.pone.0028820. Epub 2012 Jan 9.

11.

Endpoint selection and relative (versus absolute) risk reporting in published medication trials.

Hochman M, McCormick D.

J Gen Intern Med. 2011 Nov;26(11):1246-52. doi: 10.1007/s11606-011-1813-7. Epub 2011 Aug 13.

12.

Health systems and sustainability: doctors and consumers differ on threats and solutions.

Robertson J, Walkom EJ, Henry DA.

PLoS One. 2011 Apr 27;6(4):e19222. doi: 10.1371/journal.pone.0019222.

13.

Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions.

Freedland KE, Mohr DC, Davidson KW, Schwartz JE.

Psychosom Med. 2011 May;73(4):323-35. doi: 10.1097/PSY.0b013e318218e1fb. Epub 2011 May 2. Review.

14.

Integrating economic evaluation methods into clinical and translational science award consortium comparative effectiveness educational goals.

Iribarne A, Easterwood R, Russo MJ, Wang YC.

Acad Med. 2011 Jun;86(6):701-5. doi: 10.1097/ACM.0b013e318217cf25.

15.

Does simulation-based medical education with deliberate practice yield better results than traditional clinical education? A meta-analytic comparative review of the evidence.

McGaghie WC, Issenberg SB, Cohen ER, Barsuk JH, Wayne DB.

Acad Med. 2011 Jun;86(6):706-11. doi: 10.1097/ACM.0b013e318217e119. Review.

16.

Emerging role of sertindole in the management of schizophrenia.

Cincotta SL, Rodefer JS.

Neuropsychiatr Dis Treat. 2010 Sep 7;6:429-41.

Items per page

Supplemental Content

Write to the Help Desk